In addition to common anti-depression drugs, metformin as a hypoglycemic agent has been reported to have anti-depressant effects by activating the AMP-activated protein kinase (AMPK)/CREB signal pathway [45]. The gene discussed is CREB1; the disease is depressive disorder.